Inflammatory mediators in chronic heart failure in North India

被引:31
作者
Fedacko, Jan [1 ]
Singh, Ram B. [2 ]
Gupta, Aditya [2 ]
Hristova, Krasimira [3 ]
Toda, Eri [4 ]
Kumar, Adarsh [5 ]
Saxena, Manoj [2 ]
Baby, Anjum [6 ]
Singh, Ranjana [6 ]
Toru, Takahashi [7 ]
Wilson, Douglas W. [8 ]
机构
[1] Safarik Univ, Fac Med, Kosice, Slovakia
[2] Halberg Hosp & Res Inst, Moradabad 244001, Uttar Pradesh, India
[3] Univ Natl Heart Hosp, Dept Noninvas Funct Diagnost & Imaging, Sofia 1000, Bulgaria
[4] Tokai Univ Hachioji Hosp, Dept Cardiol, Tokyo, Japan
[5] Govt Med Coll, Dept Med, Amritsar, Punjab, India
[6] KG Med Univ, Dept Physiol & Biochem, Lucknow, Uttar Pradesh, India
[7] Fukuoka Womens Univ, Grad Sch Human Environm Sci, Dept Nutr, Fukuoka, Japan
[8] Univ Durham, Sch Med Pharm & Hlth, Durham, England
关键词
Antioxidants; oxidative stress; TNF-alpha; Interleukin-6; heart failure; free radical stress; mitochondria; THERAPEUTIC TARGET; EUROPEAN-SOCIETY; SURVIVAL; BIOMARKERS; TRENDS; RISK; COENZYME-Q10; ASSOCIATION; MECHANISMS; DISEASE;
D O I
10.1080/AC.69.4.3036655
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Introduction Recent evidence shows that pro-inflammatory cytokines may be important in the assessment of severity and prognosis in congestive heart failure (CHF). In the present study, we examine the association of cytokines with causes, grade and prognosis of CHF patients. Subjects and methods Of 127 patients with CHF, 11 were excluded and the remaining 116 patients with different aetiologies of CHF, and 250 age- and sex-matched control subjects, were evaluated in this case study. Severity of disease based on the New York Heart Association (NYHA) standards, fell within functional classes II to IV. The diagnosis of HF was based on clinical manifestations as well as on echocardiographic heart enlargement. Cytokines were measured by chemiluminescence. Causes of death were assessed based on death certificates. Multivariate logistic regression analysis was used to determine the risk factors of heart failure. Results Echocardiographic ejection fraction was 39.1 +/- 8.2% (mean +/- SD) in the study group indicating class II-IV heart failure. Laboratory data showed increase in biomarkers of oxidative stress, among HF patients compared to healthy subjects. Pro-inflammatory cytokines; IL-6 and TNF-alpha were significantly higher among HF patients compared to healthy subjects. TNF-alpha and IL-6, showed significant increase among patients with CHF due to ischaemic heart disease and cardiomyopathy compared to levels among CHF patients with valvular heart disease and hypertensive heart diseases. The levels of the cytokines were significantly higher among patients with class III and IV heart failure and those who died, compared to patients with class II heart failure. Multivariate logistic regression analysis revealed that CAD, cardiomyopathy, and IL-6 were strongly associated - and low ejection fraction and TNF-alpha - weakly associated with HF. Of 116 patients, 20 (17.2%) died during a follow-up of two years, and the deaths were mainly among NYHA class III and IV patients in whom the cause of CHF was CAD (10.9%) and cardiomyopathy (6.9%) which had greater levels of cytokines. Conclusions The findings indicated that pro-inflammatory cytokines may be important indicators of causes, severity of CHF and prognosis among these patients.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 32 条
[1]
Novel biomarkers in chronic heart failure [J].
Ahmad, Tariq ;
Fiuzat, Mona ;
Felker, G. Michael ;
O'Connor, Christopher .
NATURE REVIEWS CARDIOLOGY, 2012, 9 (06) :347-359
[2]
Inflammatory mediators in chronic heart failure: An overview [J].
Anker, SD ;
von Haehling, S .
HEART, 2004, 90 (04) :464-470
[3]
Targeting myocardial substrate metabolism in heart failure: potential for new therapies [J].
Ardehali, Hossein ;
Sabbah, Hani N. ;
Burke, Michael A. ;
Sarma, Satyam ;
Liu, Peter P. ;
Cleland, John G. F. ;
Maggioni, Aldo ;
Fonarow, Gregg C. ;
Abel, E. Dale ;
Campia, Umberto ;
Gheorghiade, Mihai .
EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (02) :120-129
[4]
Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990 1994 [J].
Barker, WH ;
Mullooly, JP ;
Getchell, W .
CIRCULATION, 2006, 113 (06) :799-805
[5]
Mitochondria as a Therapeutic Target in Heart Failure [J].
Bayeva, Marina ;
Gheorghiade, Mihai ;
Ardehali, Hossein .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (06) :599-610
[6]
Aspirin Use in Heart Failure Is Low-Dose Therapy Associated With Mortality and Morbidity Benefits in a Large Community Population? [J].
Bermingham, Margaret ;
Shanahan, Mary Katherine ;
O'Connell, Eoin ;
Dawkins, Ian ;
Miwa, Saki ;
O'Hanlon, Rory ;
Gilmer, John ;
McDonald, Kenneth ;
Ledwidge, Mark .
CIRCULATION-HEART FAILURE, 2014, 7 (02) :243-250
[7]
National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008 [J].
Chen, Jersey ;
Normand, Sharon-Lise T. ;
Wang, Yun ;
Krumholz, Harlan M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (15) :1669-1678
[8]
Chopra RK, 1998, INT J VITAM NUTR RES, V68, P109
[9]
Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure [J].
Dickinson, Brent A. ;
Semus, Hillary M. ;
Montgomery, Rusty L. ;
Stack, Christianna ;
Latimer, Paul A. ;
Lewton, Steven M. ;
Lynch, Joshua M. ;
Hullinger, Thomas G. ;
Seto, Anita G. ;
van Rooij, Eva .
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (06) :650-659
[10]
Relation Between Modifiable Lifestyle Factors and Lifetime Risk of Heart Failure [J].
Djousse, Luc ;
Driver, Jane A. ;
Gaziano, J. Michael .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (04) :394-400